Fundraising Fox
Mike Pellini
InvestorGeneral Partner at Section 32
Find your path to Mike
Sign up to see every warm intro you have to Mike
- Paths you didn't know you had: your email and LinkedIn already hold routes to Mike. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Former CEO of Foundation Medicine, which transformed how oncologists and pharmaceutical companies evaluate cancer's genomic drivers before Roche's 2018 acquisition. Previously President and COO of Clarient, acquired by GE Healthcare. Brings three decades of expertise in personalized medicine and cancer research.
Investments
Board seats
Per SEC Form D filings.
Colleagues at Section 32
Frequently asked questions
- Who is Mike Pellini?
- Former CEO of Foundation Medicine, which transformed how oncologists and pharmaceutical companies evaluate cancer's genomic drivers before Roche's 2018 acquisition. Previously President and COO of Clarient, acquired by GE Healthcare. Brings three decades of expertise in personalized medicine and cancer research.
- Where does Mike Pellini work?
- Mike Pellini is General Partner at Section 32.
- What boards does Mike Pellini sit on?
- Mike Pellini holds tracked board seats at Twinstrand Biosciences.
About this profile. Compiled from public sources — Section 32's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights